Your browser doesn't support javascript.
loading
Study design for development of novel safety biomarkers of drug-induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case-control study.
Grove, Jane I; Stephens, Camilla; Lucena, M Isabel; Andrade, Raúl J; Weber, Sabine; Gerbes, Alexander; Bjornsson, Einar S; Stirnimann, Guido; Daly, Ann K; Hackl, Matthias; Khamina-Kotisch, Kseniya; Marin, Jose J G; Monte, Maria J; Paciga, Sara A; Lingaya, Melanie; Forootan, Shiva S; Goldring, Christopher E P; Poetz, Oliver; Lombaard, Rudolf; Stege, Alexandra; Bjorrnsson, Helgi K; Robles-Diaz, Mercedes; Li, Dingzhou; Tran, Thi Dong Binh; Ramaiah, Shashi K; Samodelov, Sophia L; Kullak-Ublick, Gerd A; Aithal, Guruprasad P.
Afiliación
  • Grove JI; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK.
  • Stephens C; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
  • Lucena MI; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.
  • Andrade RJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.
  • Weber S; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.
  • Gerbes A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.
  • Bjornsson ES; Servicios de Aparato Digestivo Y Farmacologia Clínica, Instituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de La Victoria, Universidad de Málaga, Malaga, Spain.
  • Stirnimann G; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.
  • Daly AK; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Hackl M; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Khamina-Kotisch K; Department of Gastroenterology, Landspitali University Hospital Reykjavik, University of Iceland, Reykjavík, Iceland.
  • Marin JJG; Faculty of Medicine, University of Iceland, Reykjavík, Iceland.
  • Monte MJ; University Clinic for Visceral Surgery and Medicine, University Hospital Inselspital and University of Bern, Bern, Switzerland.
  • Paciga SA; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.
  • Lingaya M; TAmiRNA GmbH, Vienna, Austria.
  • Forootan SS; TAmiRNA GmbH, Vienna, Austria.
  • Goldring CEP; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.
  • Poetz O; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Lombaard R; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Y Digestivas (CIBERehd), Madrid, Spain.
  • Stege A; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Bjorrnsson HK; Worldwide Research Development and Medical, Pfizer, NY, USA.
  • Robles-Diaz M; Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK.
  • Li D; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
  • Tran TDB; Centre for Drug Safety Science, University of Liverpool, Liverpool, UK.
  • Ramaiah SK; Centre for Drug Safety Science, University of Liverpool, Liverpool, UK.
  • Samodelov SL; SIGNATOPE GmbH, 72770, Reutlingen, Germany.
  • Kullak-Ublick GA; ABX-CRO Advanced Pharmaceutical Services, Forschungsgesellschaft mbH, Cape Town, 7441, South Africa.
  • Aithal GP; Charité-Universitätsmedizin Berlin, Central Biobank Charité (ZeBanC), Berlin, Germany.
Diagn Progn Res ; 7(1): 18, 2023 Sep 12.
Article en En | MEDLINE | ID: mdl-37697410
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Diagn Progn Res Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Diagn Progn Res Año: 2023 Tipo del documento: Article